Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tukan Partners was a U.K.-based business development consultancy focused primarily on the biotech community. Founded in 2005 by Nigel Crockett, the firm provided hands-on commercial, transactional, licensing, and partnering support to biotech clients across Europe, the United States, and Asia. It appears to have operated as a specialist advisory business rather than a drug developer, with no disclosed therapeutic pipeline or proprietary products. U.K. Companies House records show that Tukan Partners Limited was dissolved on March 2, 2022.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tukan Partners.